FarmaTrust Rank 778
Website Twitter
600,000,000 FTT

FarmaTrust
FarmaTrust
FTT

FarmaTrust $0.00223800
₿0.0000002960

218.23 %

24h Vol
0 BTC
$10
1 H
-18.69 %
24 H
218.23 %
7 d
213.14 %
Current FarmaTrust price is 0.0022 USD, and if converted to Bitcoin is 0.00000030 BTC. A total of 178 coin's are currently circulating in the Market. FarmaTrust price change last 24 hours is 218.23 %, for more info please view all cryptocurrencies. Over the past 24 hours 0.000 M US dollars FarmaTrust has been traded on Crypto Exchanges. Track / follow FarmaTrust's progress by adding it to your favourites by creating a free portfolio if you wish.
Full Name
FarmaTrust
Symbol
FTT
Algorithm
ETH Token
BTC Price
0.00000030 BTC
BTC Market
178 BTC
BTC 24h Vol
0 BTC
Total Coins Mined
600,000,000 FTT
1h
-18.69 %
24h
218.23 %
7d
213.14 %
Twitter
Website
Share FarmaTrust Price




Description

Description


FarmaTrust is a future-proof blockchain and AI based provenance system for the pharmaceutical and healthcare sector. FarmaTrust’s digital services create efficiencies and transparency for the supply chain, eases the burden of the compliance requirements, reduces costs and eliminates counterfeit or substandard drugs. The system creates immutable and incorruptible records to ensure data integrity as well as using “smart contracts” to automate processes leading to significant cost savings for its customers. 
The security of the FarmaTrust system means greater levels of confidentiality and security which reduces the overhead of achieving regulatory compliance.
FarmaTrust provides data and AI services, to assist its customers by providing greater insights, forecasting and planning capabilities.
FarmaTrust’s products work in three vertical markets, Pharmaceutical Tracking and Data services, Cell and Gene Therapy (or Personalised Medicine), and Clinical Trials services.

ICO Details

ICO Details


)

FarmaTrust is a future-proof blockchain and AI based provenance system for the pharmaceutical and healthcare sector. FarmaTrust’s digital services create efficiencies and transparency for the supply chain, eases the burden of the compliance requirements, reduces costs and eliminates counterfeit or substandard drugs. The system creates immutable and incorruptible records to ensure data integrity as well as using “smart contracts” to automate processes leading to significant cost savings for its customers. 
The security of the FarmaTrust system means greater levels of confidentiality and security which reduces the overhead of achieving regulatory compliance.
FarmaTrust provides data and AI services, to assist its customers by providing greater insights, forecasting and planning capabilities.
FarmaTrust’s products work in three vertical markets, Pharmaceutical Tracking and Data services, Cell and Gene Therapy (or Personalised Medicine), and Clinical Trials services.

Team:

  • Lord Anthony St John of Bletso: Chairman.
  • Raja Sharif: CEO.
  • Peter Bryant: COO.
ICO Status Finished
Token Supply 600000000
Start Date N/A
End Date N/A
Fund Raised (BTC) N/A
Fund Raised (USD) N/A
Start Price (USD) 0.05
Security Audit Company N/A
ICO Legal Form N/A
ICO Jurisdiction UK
Legal Advisers N/A
Blog N/A
White Paper https://www.farmatrust.com/wp-content/uploads/2018/06/FarmaTrust_Whitepaper_v10.pdf

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer